Darden Wealth Group Inc acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,775 shares of the company’s stock, valued at approximately $295,000.
Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares in the last quarter. State Street Corp lifted its holdings in Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after purchasing an additional 195,992 shares in the last quarter. Amundi lifted its holdings in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Value Aligned Research Advisors LLC lifted its holdings in Astera Labs by 16.7% during the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after purchasing an additional 197,320 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its holdings in Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
- Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
- Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
- Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title
Insider Activity at Astera Labs
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the stock. Stifel Nicolaus lifted their price target on shares of Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. UBS Group assumed coverage on shares of Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. Morgan Stanley lifted their price target on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Finally, Loop Capital started coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective on the stock. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $233.75.
View Our Latest Report on ALAB
Astera Labs Price Performance
Astera Labs stock opened at $306.88 on Friday. The stock has a market cap of $52.60 billion, a P/E ratio of 207.35, a PEG ratio of 4.06 and a beta of 3.35. Astera Labs, Inc. has a 1 year low of $84.78 and a 1 year high of $315.81. The firm’s 50 day moving average price is $170.39 and its 200-day moving average price is $159.79.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
